Oct 1 |
Novocure to Report Third Quarter 2024 Financial Results
|
Sep 9 |
Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
|
Sep 6 |
Why NovoCure Stock Dived by 13% This Week
|
Sep 3 |
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
|
Sep 3 |
Novocure names Ashley Cordova as CEO
|
Sep 3 |
Novocure Announces Planned CEO Transition
|
Aug 28 |
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
|
Aug 16 |
Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet
|
Aug 14 |
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
|
Aug 12 |
Biotech stocks: Which drugmakers are worth a buy?
|